Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis

Journal Title: UNKNOWN - Year 2019, Vol 25, Issue 1

Abstract

.

Authors and Affiliations

Miraç Ayşen Ünsal

Keywords

Related Articles

Headache-like Subarachnoid Hemorrhage After Digital Subtraction Angiography: A Case Report

Subarachnoid hemorrhage (SAH) is a clinical condition with acute-onset, sudden, and severe headache. In addition to headache, severe nausea, vomiting, dizziness, confusion, agitation, focal neurologic deficits, and hyper...

The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results

Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to...

The Diagnosis and Treatment of Cerebral Venous Thrombosis

Cerebral venous sinus thrombosis involves thrombosis of the dural sinuses and/or cerebral veins. It constitutes 0.5-1% of all strokes and usually affects young individuals. It is slightly more common in young women due t...

Download PDF file
  • EP ID EP539573
  • DOI 10.4274/tnd.galenos.2019.00187
  • Views 89
  • Downloads 0

How To Cite

Miraç Ayşen Ünsal (2019). Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis. UNKNOWN, 25(1), 50-51. https://europub.co.uk/articles/-A-539573